Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant cell arteritis. Read more here/ ...

This week, the State Department and the Pentagon approved a $510 million sale of bomb guidance kits to Israel.

The State Department has authorized the potential sale of guidance kits for ground-penetrating bombs to Israel in a $510 million weapons package.

The US Food and Drug Administration (FDA) has granted 510 (k) clearance to Stryker’s Incompass Total Ankle System, designed for individuals whose ankle joints are damaged due to severe rheumatoid, ...

We came across a bullish thesis on Novartis AG (NVS) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on NVS.